Annual Report

Overview

The report states that consolidated net revenue reached NT$7,023,025 thousand in 2025, up approximately 3.4% from 2024. It reports about NT$260 million in 2025 research expenditure and describes launches of four pharmaceutical and nine food products. The company identifies its Board as the highest sustainability decision-making and supervisory body and established a Sustainability Development and Nomination Committee in 2025.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 20 April 2026
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services